• About Endece
  • History
  • Corporate Compliance
• Corporate Strategy
  • Management
    • James Yarger, Ph. D.
    • Steve Weitman, M.D., Ph.D.
    • Steven Nye, Ph.D.
    • Jean Yarger
  • Scientific Advisory Board
  • Strategic Advisors
  • Network

Corporate Strategy

ENDECE is focused on discovery and development of new drug candidates. The business strategy is to design and develop its library of compounds up to early clinical studies and then license its proprietary drug candidates to pharmaceutical partners.

The ENDECE business approach incorporates a collaborative model that is led by an experienced management team and supported by respected advisors and consultants as well as a network of world class research organizations.